Microchip (MCHP) Form 4: 2,491 RSUs Vested; 3,090 RSUs Granted
Rhea-AI Filing Summary
Microchip Technology Inc. (MCHP) Form 4: Non‑employee director Ellen Barker received 2,491 shares upon vesting of restricted stock units on 08/18/2025, recorded as an acquisition at a reported price of $65.56 per share, bringing her beneficial ownership to 3,797 shares. The filing also shows a grant of 3,090 restricted stock units on 08/19/2025 that are recorded as derivative awards and will convert into common stock when vested. The filing states each restricted stock unit represents the right to one share and explains vesting occurs in full on the earlier of one day before the next annual meeting or one year from grant, contingent on continued service as a non‑employee director.
Positive
- 2,491 restricted stock units vested and were delivered as common stock on 08/18/2025
- Beneficial ownership increased to 3,797 shares
- New grant of 3,090 restricted stock units recorded on 08/19/2025
- Filing identifies reporting person as a Director and provides vesting contingencies
Negative
- None.
Insights
TL;DR: Routine director RSU vesting and a new RSU grant, increasing insider ownership modestly.
The filing documents non‑employee director Ellen Barker receiving vested restricted stock units and a subsequent RSU grant. The 2,491 vested RSUs were delivered as common stock on 08/18/2025 at a reported price of $65.56, raising reported beneficial ownership to 3,797 shares. A separate grant of 3,090 RSUs on 08/19/2025 remains subject to time‑based vesting tied to continued board service and the next annual meeting or one year from grant. This is a routine governance compensation event consistent with non‑employee director equity programs; it modestly increases insider alignment with shareholders.
TL;DR: Form 4 timely reports RSU vesting and grant; disclosures follow Section 16 reporting rules.
The filing identifies the reporting person, relationship as a director, and reports both non‑derivative shares delivered upon RSU vesting and newly granted RSUs. Transaction codes and amounts are disclosed, and the explanatory remarks clarify conversion mechanics and vesting contingencies. From a compliance perspective, the form appears to report the material details required for Section 16 insiders: transaction dates, amounts, price for delivered shares, and post‑transaction beneficial ownership.